• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

免疫抑制与免疫正常患者的多发性皮肤鳞状细胞癌。

Multiple Cutaneous Squamous Cell Carcinoma in Immunosuppressed vs Immunocompetent Patients.

机构信息

Department of Dermatology, Tufts Medical Center, Boston, Massachusetts.

Tufts University School of Medicine, Boston, Massachusetts.

出版信息

JAMA Dermatol. 2019 May 1;155(5):625-627. doi: 10.1001/jamadermatol.2018.5595.

DOI:10.1001/jamadermatol.2018.5595
PMID:30865240
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6506878/
Abstract

This case-control study examines the association of multiple squamous cell carcinoma with poor outcomes in the immunosuppressed patient population.

摘要

本病例对照研究探讨了免疫抑制患者人群中多种鳞状细胞癌与不良预后的关系。

相似文献

1
Multiple Cutaneous Squamous Cell Carcinoma in Immunosuppressed vs Immunocompetent Patients.免疫抑制与免疫正常患者的多发性皮肤鳞状细胞癌。
JAMA Dermatol. 2019 May 1;155(5):625-627. doi: 10.1001/jamadermatol.2018.5595.
2
Role of human papillomavirus in cutaneous squamous cell carcinoma: a meta-analysis.人乳头瘤病毒在皮肤鳞状细胞癌中的作用：荟萃分析。
J Am Acad Dermatol. 2014 Apr;70(4):621-629. doi: 10.1016/j.jaad.2014.01.857.
3
Inferior outcomes in immunosuppressed patients with high-risk cutaneous squamous cell carcinoma of the head and neck treated with surgery and radiation therapy.头颈部高危皮肤鳞状细胞癌行手术和放疗的免疫抑制患者预后不良。
J Am Acad Dermatol. 2015 Aug;73(2):221-7. doi: 10.1016/j.jaad.2015.04.037. Epub 2015 May 29.
4
A multi-institutional comparison of outcomes of immunosuppressed and immunocompetent patients treated with surgery and radiation therapy for cutaneous squamous cell carcinoma of the head and neck.对接受手术和放射治疗的头颈部皮肤鳞状细胞癌免疫抑制患者和免疫功能正常患者的治疗结果进行多机构比较。
Cancer. 2017 Jun 1;123(11):2054-2060. doi: 10.1002/cncr.30601. Epub 2017 Feb 7.
5
Metastasis Risk of Cutaneous Squamous Cell Carcinoma in Organ Transplant Recipients and Immunocompetent Patients.器官移植受者和免疫功能正常患者皮肤鳞状细胞癌的转移风险。
Acta Derm Venereol. 2018 Jun 8;98(6):551-555. doi: 10.2340/00015555-2901.
6
Distinct immunohistochemical phenotype of nonmelanoma skin cancers between renal transplant and immunocompetent populations.肾移植和免疫功能正常人群中非黑色素瘤皮肤癌的独特免疫组织化学表型。
Transplantation. 2010 Nov 15;90(9):986-92. doi: 10.1097/TP.0b013e3181f6a0a1.
7
Squamous Cell Carcinoma of the Hand: A Retrospective Study in Immunosuppressed and Immunocompetent Individuals.手部鳞状细胞癌：免疫抑制和免疫正常个体的回顾性研究。
Dermatol Surg. 2020 Aug;46(8):1014-1020. doi: 10.1097/DSS.0000000000002336.
8
Immunosuppression and skin cancer: pathogenetic insights, therapeutic challenges, and opportunities for innovation.免疫抑制与皮肤癌：发病机制见解、治疗挑战及创新机遇
Arch Dermatol. 2002 Jun;138(6):827-8. doi: 10.1001/archderm.138.6.827.
9
Cutaneous zosteriform squamous cell carcinoma metastasis arising in an immunocompetent patient.免疫功能正常患者发生的皮肤带状疱疹样鳞状细胞癌转移。
Clin Exp Dermatol. 2002 May;27(3):199-201. doi: 10.1046/j.1365-2230.2002.01006.x.
10
Differential T-cell subset representation in cutaneous squamous cell carcinoma arising in immunosuppressed versus immunocompetent individuals.免疫抑制个体与免疫功能正常个体发生的皮肤鳞状细胞癌中T细胞亚群的差异表现。
Exp Dermatol. 2016 Mar;25(3):245-7. doi: 10.1111/exd.12878. Epub 2015 Nov 23.

引用本文的文献

1
Scalable spatial single-cell transcriptomics and translatomics in 3D thick tissue blocks.三维厚组织块中可扩展的空间单细胞转录组学和翻译组学
bioRxiv. 2024 Aug 8:2024.08.05.606553. doi: 10.1101/2024.08.05.606553.
2
Integrated Safety Analysis on Skin Cancers among Patients with Psoriasis Receiving Ixekizumab in Clinical Trials.接受司库奇尤单抗治疗的银屑病患者在临床试验中皮肤癌的综合安全性分析
Dermatol Ther (Heidelb). 2023 Aug;13(8):1773-1787. doi: 10.1007/s13555-023-00966-4. Epub 2023 Jun 23.
3
Interventions After First Post-Transplant Cutaneous Squamous Cell Carcinoma: A Proposed Decision Framework.首次移植后皮肤鳞状细胞癌后的干预措施：一个建议的决策框架。
Transpl Int. 2022 Nov 22;35:10880. doi: 10.3389/ti.2022.10880. eCollection 2022.
4
Immunotherapy to Avoid Orbital Exenteration in Patients With Cutaneous Squamous Cell Carcinoma.免疫疗法可避免皮肤鳞状细胞癌患者行眼眶内容物剜除术
Front Oncol. 2022 Jan 18;11:796197. doi: 10.3389/fonc.2021.796197. eCollection 2021.
5
Update of advanced cutaneous squamous cell carcinoma.晚期皮肤鳞状细胞癌的更新。
J Eur Acad Dermatol Venereol. 2022 Jan;36 Suppl 1(Suppl 1):6-10. doi: 10.1111/jdv.17728.
6
Comprehensive Analysis of Myeloid Signature Genes in Head and Neck Squamous Cell Carcinoma to Predict the Prognosis and Immune Infiltration.头颈部鳞状细胞癌中髓样特征基因的综合分析，以预测预后和免疫浸润。
Front Immunol. 2021 Apr 29;12:659184. doi: 10.3389/fimmu.2021.659184. eCollection 2021.
7
Head and Neck Cancer Immunotherapy beyond the Checkpoint Blockade.头颈部癌的免疫治疗：超越检查点阻断。
J Dent Res. 2019 Sep;98(10):1073-1080. doi: 10.1177/0022034519864112. Epub 2019 Jul 24.

本文引用的文献

1
Cutaneous Squamous Cell Carcinomas in Organ Transplant Recipients.器官移植受者的皮肤鳞状细胞癌
J Clin Med. 2015 Jun 3;4(6):1229-39. doi: 10.3390/jcm4061229.
2
Outcomes of Patients With Multiple Cutaneous Squamous Cell Carcinomas: A 10-Year Single-Institution Cohort Study.多发性皮肤鳞状细胞癌患者的预后：一项 10 年单机构队列研究。
JAMA Dermatol. 2015 Nov;151(11):1220-5. doi: 10.1001/jamadermatol.2015.1702.
3
Timing of subsequent new tumors in patients who present with basal cell carcinoma or cutaneous squamous cell carcinoma.患有基底细胞癌或皮肤鳞状细胞癌患者的后续新发肿瘤时间。
JAMA Dermatol. 2015 Apr;151(4):382-8. doi: 10.1001/jamadermatol.2014.3307.
4
A 10-year prospective study of patients with skin cancer.一项针对皮肤癌患者的为期10年的前瞻性研究。
J Cutan Med Surg. 2002 Sep-Oct;6(5):427-9. doi: 10.1007/s10227-001-0126-6. Epub 2002 Aug 29.
5
Risk of developing a subsequent nonmelanoma skin cancer in patients with a history of nonmelanoma skin cancer: a critical review of the literature and meta-analysis.有非黑色素瘤皮肤癌病史的患者发生后续非黑色素瘤皮肤癌的风险：文献综述与荟萃分析
Arch Dermatol. 2000 Dec;136(12):1524-30. doi: 10.1001/archderm.136.12.1524.
6
Squamous cell carcinoma. A population-based incidence study in Rochester, Minn.鳞状细胞癌。明尼苏达州罗切斯特市一项基于人群的发病率研究。
Arch Dermatol. 1990 Feb;126(2):185-8. doi: 10.1001/archderm.126.2.185.